These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 31138648

  • 1. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
    Hashimoto N, Ito S, Tsuchida A, Bhuiyan RH, Okajima T, Yamamoto A, Furukawa K, Ohmi Y, Furukawa K.
    J Biol Chem; 2019 Jul 12; 294(28):10833-10845. PubMed ID: 31138648
    [Abstract] [Full Text] [Related]

  • 2. Chemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand.
    Yamaguchi S, Yoshimura A, Yasuda Y, Mori A, Tanaka H, Takahashi T, Kitajima K, Sato C.
    Chembiochem; 2017 Jul 04; 18(13):1194-1203. PubMed ID: 28374980
    [Abstract] [Full Text] [Related]

  • 3. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
    Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR.
    Eur J Immunol; 2003 Jun 04; 33(6):1642-8. PubMed ID: 12778482
    [Abstract] [Full Text] [Related]

  • 4. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
    Kwon KM, Chung TW, Kwak CH, Choi HJ, Kim KW, Ha SH, Cho SH, Lee YC, Ha KT, Lee MJ, Kim CH.
    Int J Biol Sci; 2017 Jun 04; 13(3):265-275. PubMed ID: 28367091
    [Abstract] [Full Text] [Related]

  • 5. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.
    Avril T, Wagner ER, Willison HJ, Crocker PR.
    Infect Immun; 2006 Jul 04; 74(7):4133-41. PubMed ID: 16790787
    [Abstract] [Full Text] [Related]

  • 6. The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression.
    Zheng Y, Ma X, Su D, Zhang Y, Yu L, Jiang F, Zhou X, Feng Y, Ma F.
    J Immunol Res; 2020 Jul 04; 2020():6243819. PubMed ID: 32322597
    [Abstract] [Full Text] [Related]

  • 7. Binding specificity of siglec7 to disialogangliosides of renal cell carcinoma: possible role of disialogangliosides in tumor progression.
    Ito A, Handa K, Withers DA, Satoh M, Hakomori S.
    FEBS Lett; 2001 Aug 24; 504(1-2):82-6. PubMed ID: 11522302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9.
    Yamaji T, Teranishi T, Alphey MS, Crocker PR, Hashimoto Y.
    J Biol Chem; 2002 Feb 22; 277(8):6324-32. PubMed ID: 11741958
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
    Avril T, North SJ, Haslam SM, Willison HJ, Crocker PR.
    J Leukoc Biol; 2006 Oct 22; 80(4):787-96. PubMed ID: 16857734
    [Abstract] [Full Text] [Related]

  • 14. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T, Floyd H, Lopez F, Vivier E, Crocker PR.
    J Immunol; 2004 Dec 01; 173(11):6841-9. PubMed ID: 15557178
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2.
    Iwasawa T, Zhang P, Ohkawa Y, Momota H, Wakabayashi T, Ohmi Y, Bhuiyan RH, Furukawa K, Furukawa K.
    Int J Oncol; 2018 Apr 01; 52(4):1255-1266. PubMed ID: 29436609
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of neuronal migration by JONES antibody is independent of 9-O-acetyl GD3 in GD3-synthase knockout mice.
    Yang CR, Liour SS, Dasgupta S, Yu RK.
    J Neurosci Res; 2007 May 15; 85(7):1381-90. PubMed ID: 17385751
    [Abstract] [Full Text] [Related]

  • 17. Discovery of a new sialic acid binding region that regulates Siglec-7.
    Yamakawa N, Yasuda Y, Yoshimura A, Goshima A, Crocker PR, Vergoten G, Nishiura Y, Takahashi T, Hanashima S, Matsumoto K, Yamaguchi Y, Tanaka H, Kitajima K, Sato C.
    Sci Rep; 2020 May 26; 10(1):8647. PubMed ID: 32457377
    [Abstract] [Full Text] [Related]

  • 18. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity.
    Yeh SC, Wang PY, Lou YW, Khoo KH, Hsiao M, Hsu TL, Wong CH.
    Proc Natl Acad Sci U S A; 2016 May 17; 113(20):5592-7. PubMed ID: 27143722
    [Abstract] [Full Text] [Related]

  • 19. GD3 synthase deletion alters retinal structure and impairs visual function in mice.
    Abreu CA, Teixeira-Pinheiro LC, Lani-Louzada R, da Silva-Junior AJ, Vasques JF, Gubert F, Nascimento-Dos-Santos G, Mohana-Borges R, Matos ES, Pimentel-Coelho PM, Santiago MF, Mendez-Otero R.
    J Neurochem; 2021 Aug 17; 158(3):694-709. PubMed ID: 34081777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.